| Product Code: ETC7376431 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Grenada Oncology Companion Diagnostic Market Overview |
3.1 Grenada Country Macro Economic Indicators |
3.2 Grenada Oncology Companion Diagnostic Market Revenues & Volume, 2021 & 2031F |
3.3 Grenada Oncology Companion Diagnostic Market - Industry Life Cycle |
3.4 Grenada Oncology Companion Diagnostic Market - Porter's Five Forces |
3.5 Grenada Oncology Companion Diagnostic Market Revenues & Volume Share, By Product & Service, 2021 & 2031F |
3.6 Grenada Oncology Companion Diagnostic Market Revenues & Volume Share, By Technology(Revenue, USD Million, 2021-2031), 2021 & 2031F |
3.7 Grenada Oncology Companion Diagnostic Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.8 Grenada Oncology Companion Diagnostic Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Grenada Oncology Companion Diagnostic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Grenada |
4.2.2 Growing adoption of personalized medicine in oncology |
4.2.3 Advancements in companion diagnostic technologies |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure and resources in Grenada |
4.3.2 High costs associated with companion diagnostic tests |
4.3.3 Regulatory challenges in the approval process for companion diagnostics |
5 Grenada Oncology Companion Diagnostic Market Trends |
6 Grenada Oncology Companion Diagnostic Market, By Types |
6.1 Grenada Oncology Companion Diagnostic Market, By Product & Service |
6.1.1 Overview and Analysis |
6.1.2 Grenada Oncology Companion Diagnostic Market Revenues & Volume, By Product & Service, 2021- 2031F |
6.1.3 Grenada Oncology Companion Diagnostic Market Revenues & Volume, By Product, 2021- 2031F |
6.1.4 Grenada Oncology Companion Diagnostic Market Revenues & Volume, By Service, 2021- 2031F |
6.2 Grenada Oncology Companion Diagnostic Market, By Technology(Revenue, USD Million, 2021-2031) |
6.2.1 Overview and Analysis |
6.2.2 Grenada Oncology Companion Diagnostic Market Revenues & Volume, By Polymerase chain reaction (PCR), 2021- 2031F |
6.2.3 Grenada Oncology Companion Diagnostic Market Revenues & Volume, By Next-generation sequencing (NGS), 2021- 2031F |
6.2.4 Grenada Oncology Companion Diagnostic Market Revenues & Volume, By Immunohistochemistry (IHC), 2021- 2031F |
6.2.5 Grenada Oncology Companion Diagnostic Market Revenues & Volume, By In situ hybridization (ISH)/Fluorescence in situ hybridization (FISH), 2021- 2031F |
6.2.6 Grenada Oncology Companion Diagnostic Market Revenues & Volume, By Other technologies, 2021- 2031F |
6.3 Grenada Oncology Companion Diagnostic Market, By Type |
6.3.1 Overview and Analysis |
6.3.2 Grenada Oncology Companion Diagnostic Market Revenues & Volume, By Breast cancer, 2021- 2031F |
6.3.3 Grenada Oncology Companion Diagnostic Market Revenues & Volume, By Non-small cell lung cancer, 2021- 2031F |
6.3.4 Grenada Oncology Companion Diagnostic Market Revenues & Volume, By Colorectal cancer, 2021- 2031F |
6.3.5 Grenada Oncology Companion Diagnostic Market Revenues & Volume, By Leukemia, 2021- 2031F |
6.3.6 Grenada Oncology Companion Diagnostic Market Revenues & Volume, By Melanoma, 2021- 2031F |
6.3.7 Grenada Oncology Companion Diagnostic Market Revenues & Volume, By Prostate cancer, 2021- 2031F |
6.4 Grenada Oncology Companion Diagnostic Market, By End Use |
6.4.1 Overview and Analysis |
6.4.2 Grenada Oncology Companion Diagnostic Market Revenues & Volume, By Hospital, 2021- 2031F |
6.4.3 Grenada Oncology Companion Diagnostic Market Revenues & Volume, By Pathology/Diagnostic laboratory, 2021- 2031F |
6.4.4 Grenada Oncology Companion Diagnostic Market Revenues & Volume, By Academic medical center, 2021- 2031F |
7 Grenada Oncology Companion Diagnostic Market Import-Export Trade Statistics |
7.1 Grenada Oncology Companion Diagnostic Market Export to Major Countries |
7.2 Grenada Oncology Companion Diagnostic Market Imports from Major Countries |
8 Grenada Oncology Companion Diagnostic Market Key Performance Indicators |
8.1 Adoption rate of companion diagnostics in oncology treatments in Grenada |
8.2 Number of collaborations between pharmaceutical companies and diagnostic companies for companion diagnostic development |
8.3 Rate of reimbursement for companion diagnostic tests by healthcare payers in Grenada |
9 Grenada Oncology Companion Diagnostic Market - Opportunity Assessment |
9.1 Grenada Oncology Companion Diagnostic Market Opportunity Assessment, By Product & Service, 2021 & 2031F |
9.2 Grenada Oncology Companion Diagnostic Market Opportunity Assessment, By Technology(Revenue, USD Million, 2021-2031), 2021 & 2031F |
9.3 Grenada Oncology Companion Diagnostic Market Opportunity Assessment, By Type, 2021 & 2031F |
9.4 Grenada Oncology Companion Diagnostic Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Grenada Oncology Companion Diagnostic Market - Competitive Landscape |
10.1 Grenada Oncology Companion Diagnostic Market Revenue Share, By Companies, 2024 |
10.2 Grenada Oncology Companion Diagnostic Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here